Adjuvant therapy for pathologic stage C prostate cancer: a casualty of the PSA revolution?
Anscher
M S
MS
Department of Radiation Oncology, Duke Comprehensive Cancer Center, Duke University Medical Center, Durham, NC, 27710, USA.
D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D017430:Prostate-Specific Antigen / Q000097:blood*; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000097:blood* / Q000473:pathology / Q000628:therapy*; D018714:Radiotherapy, Adjuvant
D017430:Prostate-Specific Antigen